Pliant Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is focused on discovering and developing therapies for the treatment of fibrosis. It focuses in treating fibrosis by inhibiting integrin-mediated activation of trans... Read more
MarketWatch
CNBC
CNBC
CNBC
Access detailed stock analysis from LSEG including analyst price target estimates.